
Newleos Therapeutics
Transforming the treatment of anxiety and other neuropsychiatric disorders
Synthetic DNA is an important emerging tool in clinical medicine, pharmaceuticals, agriculture, and food. Yet research is being held back by traditional DNA synthesis techniques, which can produce only short segments of DNA. Molecular Assemblies has created an evolved polymerase enzyme that can rapidly synthesize ultra-long oligonucleotide chains with 150 or more nucleotide bases. The enzyme also eliminates the time required for purification by weeding out incomplete oligos as it goes.
Transforming the treatment of anxiety and other neuropsychiatric disorders
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
Programming stem cells to differentiate into desired cell types, faster
Using state-of-the-art machine learning models to create custom-build protein drugs